PUBLISHER: Grand View Research | PRODUCT CODE: 1814151
PUBLISHER: Grand View Research | PRODUCT CODE: 1814151
The global endoscopic probe disinfection market size was estimated at USD 478.78 million in 2024 and is projected to reach USD 791.62 million by 2033, growing at a CAGR of 5.84% from 2025 to 2033. Rising burden of healthcare-associated infections (HAIs) is anticipated to significantly contribute to the growth of the endoscopic probe disinfection market.
According to data released by the European Centre for Disease Prevention and Control (ECDC), in May 2024, it was reported that around 4.3 million hospitalized patients in the EU and European Economic Area experience healthcare-associated infections (HAIs) each year. These figures highlight the persistent challenge of infection transmission within clinical environments, where reusable medical instruments, such as endoscopes, play a critical role. This has intensified regulatory pressure on healthcare facilities to adopt more advanced, validated disinfection and sterilization practices. Subsequently, the rising burden of HAIs directly strengthens demand for reliable endoscopic probe disinfection technologies, positioning them as key tools in safeguarding patient safety and reducing hospital infection rates.
The increasing global burden of cancer and related mortality is significantly influencing the demand for advanced diagnostic and treatment modalities, including endoscopic procedures. According to the American Cancer Society article published in January 2025, the U.S. will face about 2.04 million new cancer diagnoses along with more than 618,000 related deaths in 2025, reflecting the growing burden of the disease. This rising incidence is expected to fuel the use of endoscopic procedures, which remain key to the early detection, staging, and monitoring of various cancers, particularly colorectal and gastrointestinal types. With higher procedural volumes, effective reprocessing endoscopic probes becomes even more key to minimizing infection risks and ensuring safe patient care. As a result, the anticipated increase in cancer cases directly boosts the demand for advanced endoscopic probe disinfection technologies, aligning them as essential in maintaining safety and efficiency within expanding oncology diagnostic services.
The increasing number of healthcare centers, including hospitals, oncology specialty clinics, and diagnostic centers, significantly drives the demand for endoscope probe disinfection solutions. While endoscopic procedures grow globally, reliable, efficient, and compliant reprocessing workflows are required to prevent cross-contamination and healthcare-associated infections (HAIs). With the rise in hospital infrastructure across various regions such as the U.S., UK, Italy, Spain, China, India, Brazil, South Africa, and the UAE, the procedures using both flexible and rigid endoscopes are increasing. According to the American Hospital Association, there were 6,120 hospitals in the U.S. in 2024. Similarly, Canada had 1,300 hospitals in 2021, and the European Union hosts around 15,000 hospitals. As of August 2023, the UK had 1,148 hospitals. This expanding hospital network necessitates a significant increase in disinfection and reprocessing devices.
Government authorities' growing number of regulations and guidelines regarding the disinfection of ultrasound probes is expected to create significant opportunities for market players to develop innovative disinfection products that align with these standards. For instance, in April 2024, the Association for the Advancement of Medical Instrumentation (AAMI) released a recommendation document that outlines sterile processing procedures for ultrasound probes in healthcare settings. This document provides essential guidelines for their disinfection. The increased availability of such documents from governmental and non-profit organizations is expected to boost market growth over the forecast period, offering critical information for effective probe disinfection.
Furthermore, regulatory bodies such as the FDA (Food and Drug Administration) and CDC (Centers for Disease Control and Prevention) have established strict guidelines and standards for endoscopic probe disinfection to minimize the risk of patient infections linked to inadequate reprocessing. Compliance with these protocols has become a major driver for adopting advanced disinfection technologies. In January 2025, Olympus issued a safety advisory concerning its reusable MAJ-891 Forceps/Irrigation Plug, warning that incomplete or improper cleaning of the probe channel could result in contamination. The advisory highlighted that one patient death had been linked to lapses in disinfection practices and urged healthcare providers to either transition to validated alternative accessories or rigorously follow enhanced disassembly and probe disinfection procedures to ensure patient safety. This instance emphasizes the increasing regulatory scrutiny over endoscopic probe disinfection and reinforces the market's movement toward safer, more reliable, fail-safe reprocessing solutions.
Global Endoscopic Probe Disinfection Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global endoscopic probe disinfection market report based on type, end use, and region: